Return to content in this issue

Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

Ensina LF^1,2, Cusato-Ensina AP², Camelo-Nunes IC¹, Solé D<sup>1

1</sup>Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil
²CPAlpha Clinical Research, Barueri, Brazil

J Investig Allergol Clin Immunol 2017; Vol 27(5) : 326-327
doi: 10.18176/jiaci.0179